Retatrutide, a groundbreaking tritagonist, sets itself apart by targeting not just one but three key receptors involved in weight management and glucose control. By engaging GLP-1 receptors, GIP receptors, and glucagon receptors, this experimental drug emulates the actions of three vital hormones—GLP-1, GIP, and glucagon. This unique approach aims to amplify the effects of each hormone, resulting in increased feelings of satiety, improved blood sugar regulation, and suppressed appetite.
 
Name: Retatrutide
CAS number: 2381089-83-2
Molecular formula: C221H342N46O68
Molecular weight: 4731.33
Retatrutide is a glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide 1 (GLP-1) and glucagon (GCG) multiple receptor agonist. Previous studies have shown that Retatrutide can significantly improve blood sugar control and lipid metabolism in patients with type 2 diabetes (T2D), and also has a powerful weight loss effect!
 
This product is sold for scientific research purposes only.
Product is provided as a lyophilized (freeze-dried) powder in a sealed, sterile vial.
The quantity on the label refers to the total amount of product inside each vial.
Additional lab supplies are required for conducting research such as bacteriostatic water for reconstitution, syringes  & needles to draw from the vials, and alcohol prep pads for sanitizing vial stoppers prior to needle insertion.
Vial appearance, label, seal and cap colors may vary from product photos.
 
Product Specifications: 10mg Lyophilized Powder (>99% purity)
Application: Research peptide evaluated in obesity studies
Appearance: Solid, white powder in glass ampule
Chemical Formula: C223H343F3N46O70
PubChem CID: 474492235
CAS Number: 2381089-83-2
Molecular Weight: ~4845.444 g/mol
Synonyms: Retatrutide
Storage: Store at ≤25°C, sealed, away from heat, light, and moisture.
Concentration: ≥99%